All Articles

In this episode, we sit down with Jennifer R. Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, to unpack the AMPLIFY trial that is reshaping chronic lymphocytic leukemia (CLL) treatment. She explains how this new oral combination isn’t just effective but patient-friendly, cutting down on complexity and paving the way for more accessible care. Tune in to hear how this breakthrough is setting the stage for the future of CLL therapy.

We are pleased to share our recent webinar on Metastatic Hormone-Sensitive Prostate Cancer. The webinar features Frank Dela Rama, RN, MS, AOCNS, AGN-BC (Clinical Nurse Specialist, Palo Alto, CA) and Kathryn Bowman, BS, RN, ONN-CG, OCN (GU/Neuro Navigator, Oncology, Winston-Salem, NC) discussing the biomarker testing landscape in prostate cancer as well as sharing their experiences and best practices to ensure patients receive biomarker testing at key treatment milestones. In addition, Frank and Kathryn discuss their best practices for recognizing and managing adverse events associated with the treatment of metastatic hormone-sensitive prostate cancer (mHSPC).